Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease

NCT00809003

Sjogren's Syndrome Dry Eye

COMPLETED

Impairment of Reading Ability in Dry Eye Patients

NCT01826812

Dry Eye Syndromes

COMPLETED

Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease

NCT02435914

Dry Eye Syndromes

COMPLETED PHASE2

Characterization of Subjective Discomfort in Patients With Tear Dysfunction

NCT06819631

Dry Eye Disease

NOT_YET_RECRUITING

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

NCT04030962

Dry Eye Disease Dry Eye Syndrome

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eyes Allergic Conjunctivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dry Eyes, Eye Allergies

Patients with ocular allergies and those with dry eyes.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to give informed consent
* Males and females at least 18 years of age
* Personal history of allergic disorders including but not limited to allergic conjunctivitis, allergic rhinitis, contact dermatitis and other eczema, and asthma
* Diagnosis of allergic conjunctivitis
* Presence of any of the following signs including conjunctival redness and papillae, chemosis, red edematous eyelids, reduced tear clearance, reduced TBUT, vital staining, stringy discharge, and/or symptoms including ocular itching, burning and tearing, runny nose or itchy throat

Exclusion Criteria

* Active ocular or systemic infection
* History of ocular infection within past 6 months
* Presence of punctal plugs
* Recent ocular surgery within past 6 months
* Current use of chemotherapeutic agents
* Presence of ocular trauma
* Inability to give informed consent
* Women who are pregnant, nursing or lactating

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No